Youth Nominated Support Team for Suicidal Adolescents at Clinical High Risk for Psychosis
Project Number5R34MH126063-03
Former Number1R34MH126063-01A1
Contact PI/Project LeaderSCHIFFMAN, JASON E Other PIs
Awardee OrganizationUNIVERSITY OF CALIFORNIA-IRVINE
Description
Abstract Text
PROJECT SUMMARY / ABSTRACT
Psychotic disorders are characterized by high rates of suicidal ideation and behavior, and the risk for
suicide appears to be greatest during the earliest stages of psychosis. A recent meta-analysis
showed that the majority of youth at clinical high-risk (CHR) for psychosis experience suicidal
ideation, and that approximately one in five make at least one suicide attempt. There are, however,
no suicide prevention interventions specifically tailored to the needs of transition-aged youth at CHR,
and no current best practice guidelines for how to respond to suicide risk in this population. The
Youth-Nominated Support Team (YST) intervention has recently been shown to reduce mortality
among adolescents and is potentially highly adaptable within the context of existing CHR services.
YST is intended as an adjunctive treatment and is primarily delivered towards support persons rather
than the youth themselves, and therefore would not interfere or overlap with the already extensive
direct services provided in CHR treatment settings. The proposed project intends to adapt the YST
intervention for CHR populations and to provide pilot efficacy data for a larger subsequent
randomized trial. Specifically, we aim to: (1) adapt YST for CHR based on stakeholder input (i.e.,
clients, family/friends, clinicians) and to develop a new treatment manual; (2) to implement YST in a
single CHR clinic and to revise the intervention based on input from clients, providers, and support
persons, and (3) to conduct a pilot randomized clinical trial at four SAMHSA funded CHR sites. For
the first stage of this study, we intend to conduct six focus groups (two of clients, two of family
members, and two of clinicians) to gather input on needs and preferences regarding suicide
prevention. This information will be incorporated into the YST protocol through expert consensus
meetings (i.e., study investigators, clinicians, and consultants) and used to develop a treatment
manual. During the second stage of the project, we will conduct a small feasibility study using this
intervention manual at the primary study site (N=8), and will again gather input from clients, providers,
and support persons to further revise the treatment manual. In the final stage, we will conduct a pilot
randomized clinical trial of the adapted YST intervention at four CHR clinics (N=70), comparing the
adapted YST intervention to an active control condition consisting of safety planning, crisis resources,
and means restriction. The proximal targets will be social connectedness, hope, and treatment
engagement, and the distal targets suicidal ideation and behavior (e.g., attempts, preparatory
actions). This study will provide the first clinical trial data for targeted suicide prevention among the
CHR population. Findings will inform best practices for addressing suicide risk in the CHR phase of
illness and facilitate the development of a subsequent larger randomized clinical trial incorporating
additional CHR clinics to further test the efficacy of the adapted YST intervention and to identify
underlying mechanisms of change.
Public Health Relevance Statement
PROJECT NARRATIVE
Suicidal ideation and behaviors are common across the psychosis continuum, particularly among
youth experiencing the earliest signs and symptoms of a psychotic disorder. Despite the high risk
for suicidal ideation and behavior in this group, there are currently no suicide prevention
approaches specifically designed for youth at clinical high-risk for psychosis. This project will adapt
the evidence-based “Youth-Nominated Support Teams” intervention, tailoring it for transition-aged
youth and young adults receiving clinical high-risk for psychosis mental health services. Using
client, family, and stakeholder input, we will develop, implement, and revise the intervention, and
then test its impact in a preliminary randomized trial at four psychosis-risk clinics.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdherenceAdolescentAdolescent and Young AdultCaringClientClinicClinicalClinical ResearchClinical TrialsCollaborationsConsensusCoordinated Specialty CareDataDeath RateDevelopmentDiagnosisDissemination and ImplementationDistalEarly InterventionEvidence based practiceExclusionFamilyFamily memberFeasibility StudiesFeeling hopelessFeeling suicidalFocus GroupsFriendsFundingGrantHealth behaviorImpairmentIndividualInterventionInterviewManualsMental HealthMental Health ServicesMeta-AnalysisModelingParticipantPersonsPhasePopulationPractice GuidelinesPreparationPrevalencePrevention approachProtocols documentationProviderPsychosesPsychotic DisordersRandomizedRandomized, Controlled TrialsRecording of previous eventsRecoveryReportingResearch PersonnelResourcesSafetySchizophreniaSelf-Injurious BehaviorServicesSigns and SymptomsSiteSocial isolationSocial supportStructureSuicideSuicide attemptSuicide preventionTestingTrainingTreatment ProtocolsUnited States Substance Abuse and Mental Health Services AdministrationYouthacceptability and feasibilityactive controlagedbrief interventionclinical high risk for psychosiscomparative efficacycost effectivedepressive symptomsdesignduration of untreated psychosisefficacy testingevidence baseexperiencefeasibility testingfollow-uphealth service usehigh riskhigh risk populationintervention deliverymeetingsmortalityperson centeredpilot trialpreferenceprevention servicepreventive interventionprogramspsychoeducationpsychosis riskrandomized trialrandomized, clinical trialsreducing suicideresponsesocialsuccesssuicidal adolescentsuicidal behaviorsuicidal risksuicide ratesupport networktelehealthtreatment riskyoung adult
No Sub Projects information available for 5R34MH126063-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R34MH126063-03
Patents
No Patents information available for 5R34MH126063-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R34MH126063-03
Clinical Studies
No Clinical Studies information available for 5R34MH126063-03
News and More
Related News Releases
No news release information available for 5R34MH126063-03
History
No Historical information available for 5R34MH126063-03
Similar Projects
No Similar Projects information available for 5R34MH126063-03